This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Nano Labs Appoints Dr. David Perry To The Board Of Advisors

DETROIT, May 2, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp . (OTCQB:CTLE) , a nanotechnology research and development company focused on creating a portfolio of advanced products in the consumer, energy, materials and healthcare industries, is pleased to announce today that Dr. David Perry has joined Nano Labs' Board of Advisors.

Dr. Perry is recognized worldwide as an expert in Technology Innovation and has held a number of senior management positions throughout his career spanning 5 continents and 35 years, both in Industry and Academia.

Dr. Perry studied at the Pasteur Institute in Paris, has authored over 40 papers and patents and has worked with and/or founded a very broad range of companies, from start-ups to multinationals in, Innovation Management, High Technology, Biotechnology, Pharmaceuticals, Cosmetics, Agro-food and Clean Technology.

Dr. Perry is currently Director of Development and International Affairs at Hautes Etudes d'Ingénieur (HEI), Ingénieurs pour le Monde (Engineers for the World), a member of the CGE, the French Ivy League of Engineering and Business Schools, where he has successfully deployed his technical, managerial and political skills in expanding the Global Industrial and Academic Programs and Partnerships at HEI.

"I am indeed both honored and proud to be a part of Nano Labs, the people are engaged, the markets are ready, the technologies are empowering, the impact on people's welfare is evident and the good they can do for the World, unmistakable," states Dr. Perry.

Dr. Perry has held positions as an Adjunct Professorship at the following institutions: School of Applied Biology, Paris, France; University of Toulouse, France; Barcelona University, Spain; Düsseldorf University, Germany; Armand Frappier Institute, Montreal, Canada; Laval University, Ste. Foy, Quebec, Canada; Concordia University, Montreal, Canada; University of Waterloo, Waterloo, Ontario, Canada and the University of Wageningen, Holland; and as a Visiting Professor at the University of Virginia, Mountain Lake Biological Station.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs